In modern healthcare, the value of a versatile and high‑performance ultrasound platform cannot be overstated. The LOGIQ Fortis ultrasound system from GE HealthCare brings next‑generation imaging technologies into a single, compact solution that supports confident diagnostics across a wide range of clinical applications – with particular strengths in breast imaging and mammography workflows.

Ultrasound plays an increasingly important role in the assessment and characterisation of breast lesions, especially when findings from mammography require further evaluation. While mammography remains the cornerstone of breast cancer screening, ultrasound is widely used as a highly sensitive supplemental modality to help resolve ambiguities, distinguish solid masses from cysts, guide interventions and support biopsy procedures. With its powerful image quality, advanced flow imaging and AI‑based decision support tools, LOGIQ Fortis enhances clinicians’ ability to evaluate breast anatomy with exceptional clarity and confidence.

At the heart of LOGIQ Fortis is GE HealthCare’s cSound™ architecture, which delivers high‑resolution images by ensuring all pixels throughout the image are in focus, from near field to depth, and supporting sensitive vascular imaging for detailed assessment of tissue perfusion. This capability is especially valuable in breast imaging, where subtle textural variances and microvascular patterns can carry critical diagnostic clues.

To support mammography‑related workflows, LOGIQ Fortis integrates AI‑based assistant tools such as the Breast Assistant powered by Koios DS™. This intelligent feature helps radiologists reduce operator variability, automatically analyse lesions and provide quantitative assessments that support BI‑RADS classification, helping to focus decision‑making and potentially reduce unnecessary biopsies.

Beyond breast imaging, LOGIQ Fortis is engineered as a multi‑purpose system capable of delivering excellent performance across virtually every ultrasound application. From abdominal and liver assessments using advanced quantification tools like 2D shear wave elastography and Ultrasound‑Guided Attenuation Parameter (UGAP) to musculoskeletal, thyroid, vascular, paediatric and point‑of‑care imaging, this system adapts fluidly to the needs of diverse clinical environments.

Another key advantage of LOGIQ Fortis is its ergonomic design and workflow‑enhancing features. The intuitive EZ Imaging interface, customisable presets and streamlined touch controls reduce keystrokes and setup time, enabling clinicians of all experience levels to work efficiently even in high‑volume settings. Its mobility including battery‑powered scanning and remote operation capabilities means the system can be used at bedside, in examination rooms or in interventional suites with ease.

For departments seeking a scalable platform that supports ongoing innovation, LOGIQ Fortis also includes a robust digital ecosystem. This encompasses remote performance analytics, advanced system diagnostics, cybersecurity protection with GE’s multi‑layer SonoDefense approach and access to clinical applications and future upgrades.

In Ireland, healthcare providers now have access to LOGIQ Fortis through MDI Medical, backed by comprehensive support that includes installation, on‑site training, workflow integration and ongoing technical service. This ensures clinicians can fully leverage the system’s capabilities from the very start, helping to deliver high‑quality ultrasound across breast imaging and beyond.